Reply to: How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia
W
William G. Wierda
(The University of Texas MD Anderson Cancer Center, Houston, Texas, United States)
C
Ching Ching Leow
(21Eli Lilly and Company, Indianapolis, United States)
A
Amy S. Ruppert
(William G. Wierda, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Ching Ching Leow, MD, Amy S. Ruppert, PhD, and Yuanyuan Bian, PhD, Eli Lilly and Company, Indianapolis, IN; and Jennifer A. Woyach, MD, The Ohio State University Comprehensive Cancer Center, Columbus, OH)
Y
Yuanyuan Bian
(21Eli Lilly and Company, Indianapolis, United States)
J
Jennifer A. Woyach
(5Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 19
Published
July 01, 2026
Pages
1847-1851
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (5)
W
William G. Wierda
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
C
Ching Ching Leow
21Eli Lilly and Company, Indianapolis, United States
A
Amy S. Ruppert
William G. Wierda, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Ching Ching Leow, MD, Amy S. Ruppert, PhD, and Yuanyuan Bian, PhD, Eli Lilly and Company, Indianapolis, IN; and Jennifer A. Woyach, MD, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Y
Yuanyuan Bian
21Eli Lilly and Company, Indianapolis, United States
J
Jennifer A. Woyach
5Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001